Murphy Julie A, Schroeder Michelle N, Rarus Rachel E, Yakubu Idris, McKee Sean O P, Martin Steven J
1 Department of Pharmacy Practice, University of Toledo College of Pharmacy and Pharmaceutical Sciences, Toledo, OH, USA.
2 Department of Pharmacy Services, University of Toledo Medical Center, Toledo, OH, USA.
J Pharm Pract. 2019 Feb;32(1):68-76. doi: 10.1177/0897190017743129. Epub 2017 Nov 28.
: Pharmacists may assist with reducing 30-day readmission rates for patients with heart failure (HF) exacerbation or acute myocardial infarction (AMI) by promoting medication adherence.
: To determine the change in 30-day readmission rates for patients with HF exacerbation or AMI after implementation of a "high-touch" standard of care.
: Patients admitted with HF exacerbation, non-ST-segment elevation AMI, or ST-segment elevation AMI from August 1, 2013, to June 30, 2015, were included in this prospective study. Patients were educated while in the inpatient setting and followed up in the outpatient setting through telephone contact and scheduling a medication therapy management (MTM) appointment with a pharmacist. Data were collected by pharmacy personnel involved in the implementation of the intervention.
: Within the HF and AMI arms, 100 and 93 patients, respectively, were included in the study. The 30-day readmission rates were 24% and 17.2% for HF and AMI, respectively, which were not statistically significant when compared to historical institutional readmission rates prior to study initiation (18.2% for HF, P = .238; 11.4% for AMI, P = .252).
: A "high-touch" pharmacist-driven transitions of care program may affect 30-day readmission rates for patients with HF exacerbation or AMI; potential processes for initiating transitions of care programs are provided.
药剂师可通过促进药物依从性来帮助降低心力衰竭（HF）加重或急性心肌梗死（AMI）患者的30天再入院率。
确定实施“高接触”护理标准后，HF加重或AMI患者30天再入院率的变化。
本前瞻性研究纳入了2013年8月1日至2015年6月30日期间因HF加重、非ST段抬高型AMI或ST段抬高型AMI入院的患者。患者在住院期间接受教育，并在门诊通过电话联系及安排与药剂师的药物治疗管理（MTM）预约进行随访。数据由参与干预实施的药房人员收集。
在HF组和AMI组中，分别有100例和93例患者纳入研究。HF组和AMI组的30天再入院率分别为24%和17.2%，与研究开始前的历史机构再入院率相比无统计学意义（HF组为18.2%，P = 0.238；AMI组为11.4%，P = 0.252）。
由药剂师推动的“高接触”护理过渡计划可能会影响HF加重或AMI患者的30天再入院率；提供了启动护理过渡计划的潜在流程。
